“Ustekinumab treats psoriasis by suppressing RORC and T-box but its suppression of GATA restrains its efficacy”, Braz. J. Pharm. Sci., vol. 54, no. 4, p. e17349, Dec. 2018, doi: 10.1590/s2175-97902018000417349.